Citadel Advisors’s Counterpath Corp CPAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CPAH
WS
Citadel Advisors's CPAH Position: Q4 2019 in Review
Citadel Advisors sold out of Counterpath Corp (CPAH) in Q4 2019, closing a stake of 12,290 shares — an estimated $14K sold.
Citadel Advisors first reported a position in CPAH in Q3 2013 and held it in 11 quarters. The position peaked at $49K in Q1 2019. 8 funds tracked by Wall St. Rank hold CPAH as of Q4 2019.
- Citadel Advisors reported no remaining Counterpath Corp position as of Q4 2019 after selling out during the quarter.
- Citadel Advisors sold 12,290 Counterpath Corp shares in Q4 2019, an estimated $14K.
- Citadel Advisors first reported a position in Counterpath Corp in Q3 2013 and held it in 11 quarters.
- Citadel Advisors's Counterpath Corp position peaked at $49K in Q1 2019.
- 8 funds tracked by Wall St. Rank held Counterpath Corp as of Q4 2019.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.